Showing results (1-10 of 34) with videos related to

Sort By:
Pageof 4
Cancers|March 8, 2019
Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer TherapyGloria Manzotti, Alessia Ciarrocchi, Valentina Sancisi
International Journal of Cancer|May 16, 2014
Time to re-consider the meaning of BRAF V600E mutation in papillary thyroid carcinomaGreta Gandolfi, Valentina Sancisi, Simonetta Piana, et al.
Trends in Biochemical Sciences|September 28, 2020
YAP and TAZ Are Not Identical TwinsFrancesca Reggiani, Giulia Gobbi, Alessia Ciarrocchi, et al.
Cancer Research|March 15, 2015
Histone Deacetylase Inhibitors Repress Tumoral Expression of the Proinvasive Factor RUNX2Valentina Sancisi, Greta Gandolfi, Davide Carlo Ambrosetti, et al.
The Journal of Clinical Endocrinology and Metabolism|June 29, 2012
BRAFV600E mutation does not mean distant metastasis in thyroid papillary carcinomasValentina Sancisi, Davide Nicoli, Moira Ragazzi, et al.
Experimental & Molecular Medicine|December 18, 2025
EGLN1 (PHD2) role in tumor microenvironment: insights for therapeutic targetingGiulio Verna, Valentina Fantini, Alessandra Grieco, et al.
Cell Death & Disease|December 9, 2016
Autophagy and epithelial-mesenchymal transition: an intricate interplay in cancerMila Gugnoni, Valentina Sancisi, Gloria Manzotti, et al.
Oncogene|June 15, 2022
The multifaceted role of EGLN family prolyl hydroxylases in cancer: going beyond HIF regulationSilvia Strocchi, Francesca Reggiani, Giulia Gobbi, et al.
Biochimica Et Biophysica Acta. Reviews on Cancer|January 14, 2020
Multiple roles and context-specific mechanisms underlying YAP and TAZ-mediated resistance to anti-cancer therapyFrancesca Reggiani, Giulia Gobbi, Alessia Ciarrocchi, et al.
European Journal of Endocrinology|January 14, 2015
TERT promoter mutations are associated with distant metastases in papillary thyroid carcinomaGreta Gandolfi, Moira Ragazzi, Andrea Frasoldati, et al.
Pageof 4